External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer.

Mednet Member

Radiation Oncology · Case Western Reserve University/ University Hospitals Seidman Cancer Center

The short answer is, YES I would, in general, recommend treatment. I also respectfully disagree that ADT monotherapy is the standard of care. It is an option of course, but rarely performed given it is non-curative and the data to support its use is of minimal relevance today.Some key points of reas...